Victoria Collins

This news makes for yet another disappointing day for the UK’s investment landscape. We could be a global leader in innovation, but ever since the previous Conservative Government’s scrapping of the industrial strategy businesses have been left with uncertainty. The life sciences sector is vital not just for economic growth, but for our health and technological innovation. It contributes over £43 billion to the UK economy, supports thousands of highly skilled jobs and drives breakthroughs in medicine and healthcare, yet in conversations that I have had with businesses, I have heard time and again how the UK’s fragmented approach to investment is holding them back. That is why I have highlighted those concerns in previous questions to the Secretary of State. The Government have promised to publish “Invest 2035” this spring, but right now companies still have no detail on what support will be available and when. Without urgent action, we risk more world-leading firms following AstraZeneca’s lead and taking their investments elsewhere. Will the Minister please confirm exactly when the final Invest 2035 strategy will be published? The Government said that the decision was based on value for money, so will the Minister and the Secretary of State also publish the impact assessment, so that we can see for ourselves?